REFERENCES
- Owens D GC, Johnstone E C. The disabilities of chronic schizophrenia - their nature and the factors contributing to their development. British Journal of Psychiatry 1980; 136: 384–395
- McCreadie R G, Barron E T, Winslons G S. The Nithsdale Schizophrenia Survey: II. Abnormal movements. British Journal of Psychiatry 1982; 140: 587–590
- Karson C R, Jeste O V, Bigelow L B. Tardive dyskinesia and psychopathology in chronic schizophrenia: cross-sectional study. Comprehensive Psychiatry 1985; 26: 388–391
- Itil T M, Reisberg B, Huque M, et al. Clinical profiles of tardive dyskinesia. Comprehensive Psychiatry 1981; 22: 282–290
- Csernansky J G, Kaplan J, Holman C A, et al. Serum neuroleptic activity, prolactri, and tardive dyskinesia in schizophrenic outpatients. Psychopharmacology 1983; 81: 115–118
- Jeste D V, Karson C N, lager A C, et al. Association of abnormal involuntary movements and negative symptoms. Psychopharmacology Bulletin 1984; 20: 380–381
- Glazer W M, Moore D C, Schooler N R, et al. Tardive dyskinesia - a discontinuation study. Archive of General Psychiatry 1984; 41: 623–627
- Waddington J L, Youssef H A, Molloy A G, et al. Association of intellectual impairment, negative symptoms, and aging with tardive dyskinesia: clinical and animal studies. Journal of Clinical Psychiatry 1985; 46: 29–33
- Guy W, Ban T A, Wilson W H. The prevalence of abnormal involuntary movements among chronic schizophrenics. International Clinical Psychopharmacology 1986; 1: 134–144
- Waddington J L, Youssef H A. Late onset involuntary movements in chronic schizophrenia: relationship of “tardive” dyskinesia to intellectual impairment and negative symptoms. British Journal of Psychiatry 1986; 149: 616–620
- Barnes T RE, Liddle P F, Curson D A, et al. Negative symptoms, tardive dyskinesia and depression in chronic schizophrenia. British Journal of Psychiatry 1989; 155(supp 7)99–103
- Karson C N, Brache H S, Powell A, et al. Dyskinetic movements, cognitive impairment and negative symptoms in elderly neuropsychiatric patients. American Journal of Psychiatry 1990; 147: 1646–1649
- Hoffman W F, Labs S, Casey D E. Neuroleptic-induced Parkinsonism in older schizophrenics. Biological Psychiatry 1987; 22: 427–439
- Lindenmayer J P, Kay S R, Opler L. Positive and negative subtypes in acute schizophrenia. Comprehensive Psychiatry 1984; 25: 455–464
- Opler L A, Kay S K, Rosado V, et al. Positive and negative syndromes in chronic schizophrenia inpatients. Journal of Nervous and Mental Disease 1984; 172: 317–325
- Richardson M A, Pass R, Bregman Z, et al. Tardive dyskinesia and depressive symptoms in schizophrenia. Psychopharmacology Bulletin 1985; 21: 130–135
- lager A C, Kirch D G, Jeste D V, et al. Defect symptoms and abnormal involuntary movement in schizophrenia. Biological Psychiatry 1986; 21: 751–755
- Monteleone P, Maj M, Ariano M G, et al. Protection response to sodium valproate in schizophrenia with and without tardive dyskinesia. Psychopharmacology 1988; 96: 223–226
- Bartzokis G, Hill M A, Altshular L. Tardive dyskinesia in schizophrenia patients: correlation with negative symptoms. Psychiatry Research 1989; 28: 145–151
- Andreasen N C. Negative symptoms in schizophrenia -Definition and reliability. Archives of General Psychiatry 1982; 39: 784–788
- Somers A A. Negative symptoms: conceptual and methological problems. Schizophrenia Bulletin 1985; 11: 366–380
- DeLeon J, Wilson W H, Simpson G M. Measurement of negative symptoms in schizophrenia. Psychiatric Developments 1989; 3: 211–234
- Chiu H, Shum P, Lau J, et al. Prevalence of tardive dyskinesia, tardive dystonia and respiratory dyskinesia in Chinese psychiatric patients in Hong Kong. American Journal of Psychiatry 1992; 149: 1081–1085
- National Institute of Mental Health. Abnormal Involuntary Movement Scale, in ECDEU Assessment Manual, W. Guy Rockville, M D. US Department of Health, Education and Welfare. 1976
- Schooler N R, Kane J M. Research diagnoses for tardive dyskinesia. Archives of General Psychiatry 1982; 39: 486–487
- Andreasen N C. Scale for the Assessment of Negative Symptoms (SANS). University of Iowa Press, Iowa City 1981
- Montgomery S, Asberg M. A new depression scale designed to be sensitive to change. British Journal of Psychiatry 1979; 134: 382–389
- Schlesselman J J. Case Control Studies. Oxford University Press, New York 1982
- Davis J M. Comparative doses and costs of antipsychotic medication. Archives of General Psychiatry 1976; 33: 858–861